机器人辅助人工尿道括约肌植入术治疗男性神经源性尿失禁的疗效
该单中心回顾性研究纳入2011年1月至2018年8月共19例接受机器人辅助腹腔镜人工尿道括约肌植入术(R-AUS)的成年男性神经泌尿患者,中位年龄45岁,中位随访58个月,末次随访时控尿率89.5%,翻修率5.3%,无翻修取出,早期轻微并发症发生率15.8%。
要点
- R-AUS在男性神经源性 stress 尿失禁中控尿率89.5%,翻修率5.3%。
- 早期轻微并发症(Clavien-Dindo I-II级)发生率为15.8%。
- 无中转开放手术,无AUS取出,中位随访58个月。
核心结论
- R-AUS是成年男性神经泌尿患者植入AUS安全有效的方法,可参考具有挑战性的开放技术。
研究设计与样本
- 单中心回顾性研究,纳入2011年1月至2018年8月所有连续接受R-AUS的成年男性神经泌尿患者,共19例,中位年龄45岁(IQR 37-54)。
主要发现
- 无中转开放手术;3例(15.8%)发生早期轻微术后并发症(Clavien-Dindo I-II级)。
- 中位随访58个月(IQR 36-70),末次随访控尿率89.5%。
- AUS翻修率5.3%,取出率0%。
关键数值与推荐
- 控尿定义为不使用尿垫。
- 并发症采用Clavien-Dindo分级报告。
临床怎么用
- 对于成年男性神经源性 stress 尿失禁,R-AUS可作为AUS植入的安全有效选择。
局限性
- 单中心回顾性设计,样本量小(19例),随访时间有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To report the functional outcomes of robot-assisted laparoscopic artificial urinary sphincter implantation (R-AUS) in men with neurogenic stress urinary incontinence (SUI). PATIENTS AND METHODS: A monocentric retrospective study included all consecutive adult male neuro-urological patients who underwent R-AUS for SUI between January 2011 and August 2018. The AUS was implanted via a transperitoneal robot-assisted laparoscopic approach. Intraoperative and early postoperative complications were reported (Clavien-Dindo classification). Continence was defined as no pad usage. Revision and explantation rates were also evaluated. RESULTS: Overall, 19 men with a median (interquartile range [IQR]) age of 45 (37-54) years were included. No conversion to laparotomy was needed. Three minor (Clavien-Dindo Grade I-II) early postoperative complications occurring in three (15.8%) patients were reported. The median (IQR) follow-up was 58 (36-70) months. At the end of the follow-up, the continence rate was 89.5%. The AUS revision and explantation rates were 5.3% and 0%, respectively. CONCLUSION: A R-AUS is a safe and efficient procedure for AUS implantation in adult male neuro-urological patients, referring to the challenging open technique.
引用
- Chartier-Kastler E, Guillot-Tantay C, Ruggiero M, et al. Outcomes of robot-assisted urinary sphincter implantation for male neurogenic urinary incontinence. BJU Int. 2021. PMID: 34174147. doi:10.1111/bju.15528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。